公开(公告)号：EP0630190A4

公开(公告)日：1995-05-17

申请号：EP93904973

申请日：1993-02-08

Applicant: ABBOTT LAB

Inventor： KATZ GARY EDWARD ,  GUZMAN-HARTY MELINDA

IPC: A23L1/30 ,  A23L1/302 ,  A23L3/3454 ,  C11B5/00 ,  A23L1/303

CPC classification number: C11B5/0092 ,  A23L3/3454 ,  A23L33/115 ,  A23L33/15 ,  A23V2002/00 ,  Y10S426/801 ,  A23V2250/5424 ,  A23V2250/1882 ,  A23V2250/188 ,  A23V2250/1868 ,  A23V2250/708 ,  A23V2250/211 ,  A23V2250/032 ,  A23V2250/54 ,  A23V2250/60 ,  A23V2250/156 ,  A23V2250/712

Abstract: A powdered nutritional product has an oil blend which contains soy oil and/or marine oil. In order to minimize oxidation of the product an antioxidant system of natural ingredients is incorporated therein. The antioxidant system is made up of ascorbyl palmitate, beta carotene and/or mixed tocopherols, and citrate.

公开(公告)号：ES2185975T3

公开(公告)日：2003-05-01

申请号：ES97936999

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： MAZER TERRY BRUCE ,  ANDERSON STEVEN N ,  GUZMAN-HARTY MELINDA ,  HILTY MILO DUANE ,  LEE THERESA SIU-LING WAI ,  SHALLER JOSEPH

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：AT224355T

公开(公告)日：2002-10-15

申请号：AT97936999

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： MAZER TERRY BRUCE ,  ANDERSON STEVEN N ,  GUZMAN-HARTY MELINDA ,  HILTY MILO DUANE ,  LEE THERESA SIU ,  SHALLER JOSEPH ,  LIU JIN-ZHOU

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：DE69715637D1

公开(公告)日：2002-10-24

申请号：DE69715637

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： MAZER BRUCE ,  ANDERSON N ,  GUZMAN-HARTY MELINDA ,  HILTY DUANE ,  LEE SIU-LING ,  SHALLER JOSEPH ,  LIU JIN-ZHOU

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：CA2257412A1

公开(公告)日：1998-02-05

申请号：CA2257412

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： SCHALLER JOSEPH ,  LEE THERESA SIU-LING WAI ,  ANDERSON STEVEN N ,  LIU JIN-ZHOU ,  MAZER TERRY BRUCE ,  HILTY MILO DUANE ,  GUZMAN-HARTY MELINDA

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70 ,  C07C305/06 ,  C07F9/09

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred watermiscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：PT918742E

公开(公告)日：2003-02-28

申请号：PT97936999

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： LIU JIN-ZHOU ,  MAZER TERRY BRUCE ,  ANDERSON STEVEN N ,  GUZMAN-HARTY MELINDA ,  HILTY MILO DUANE ,  LEE THERESA SIU-LING WAI ,  SHALLER JOSEPH

IPC: A61K31/225 ,  A61P31/04 ,  A61P31/12 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：DK0918742T3

公开(公告)日：2002-12-09

申请号：DK97936999

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： MAZER TERRY BRUCE ,  ANDERSON STEVEN N ,  GUZMAN-HARTY MELINDA ,  LEE THERESA SIU-LING WAI ,  SHALLER JOSEPH ,  LIU JIN-ZHOU ,  HILTY MILO DUANE

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：DE69715637T2

公开(公告)日：2003-08-07

申请号：DE69715637

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： MAZER BRUCE ,  ANDERSON N ,  GUZMAN-HARTY MELINDA ,  HILTY DUANE ,  LEE SIU-LING ,  SHALLER JOSEPH ,  LIU JIN-ZHOU

IPC: A61P31/12 ,  A61K31/225 ,  A61P31/04 ,  C07C69/70

Abstract: The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

公开(公告)号：CA2257421A1

公开(公告)日：1998-02-05

申请号：CA2257421

申请日：1997-07-23

Applicant: ABBOTT LAB

Inventor： LIU JIN-ZHOU ,  LAMM JILL M ,  MAZER TERRY B ,  BOWMAN TAMMY MARIE ,  LEE THERESA SIU-LING WAI ,  ANDERSON STEVEN N ,  GUZMAN-HARTY MELINDA ,  HILTY MILO DUANE ,  SCHALLER JOSEPH

IPC: A23L1/30 ,  A61K31/22 ,  A61K31/23 ,  A61P31/12 ,  A61P31/16 ,  A61P31/18 ,  A61P31/22

Abstract: A nutritional formulation containing an amount of diacetyltartaric acid esters of mono- and diglycerides effective to inhibit the infectious activity of pathogenic microorganisms is provided. A method of inhibiting the infectious activity of pathogenic microorganisms including the step of feeding the nutritional composition to a subject is also provided.

公开(公告)号：NZ249395A

公开(公告)日：1995-11-27

申请号：NZ24939593

申请日：1993-02-08

Applicant: ABBOTT LAB

Inventor： KATZ GARY EDWARD ,  GUZMAN-HARTY MELINDA

IPC: A23L1/30 ,  A23L3/3454 ,  A23L33/15 ,  C11B5/00 ,  A23L1/03 ,  A23L1/303

Abstract: A powdered nutritional product has an oil blend which contains soy oil and/or marine oil. In order to minimize oxidation of the product an antioxidant system of natural ingredients is incorporated therein. The antioxidant system is made up of ascorbyl palmitate, beta carotene and/or mixed tocopherols, and citrate.